Acetylation in renal physiology and pathophysiology.

Area of Science:

• Nephrology
• Biochemistry
• Molecular Biology

Background:

• Kidney diseases like AKI and CKD are significant global health concerns.
• Protein acetylation, regulated by HDACs and SIRTs, influences kidney pathophysiology.
• Understanding these enzymes is crucial for developing new kidney disease treatments.

Purpose of the Study:

• To review the roles and mechanisms of HDACs and SIRTs in kidney diseases.
• To explore the therapeutic potential of HDAC inhibitors and SIRT activators in kidney protection.
• To discuss the dual roles of SIRTs in kidney injury and protection.

Main Methods:

• Literature review of studies on HDACs, SIRTs, and kidney diseases.
• Analysis of mechanisms underlying acetylation's impact on renal pathophysiology.
• Examination of therapeutic strategies involving HDAC inhibitors and SIRT modulators.

Main Results:

• HDACs and SIRTs significantly influence kidney disease progression through protein acetylation.
• Some SIRTs exhibit dual roles, offering protection or causing injury depending on the context.
• HDAC inhibitors and SIRT activators show promise in preclinical and clinical settings for kidney protection.

Conclusions:

• HDACs and SIRTs are key regulators in kidney diseases, offering therapeutic targets.
• Targeting SIRTs, especially those with dual roles, requires careful consideration for effective kidney disease management.
• Further research into HDAC and SIRT modulation holds significant potential for novel kidney disease therapies.